EKF Diagnostics, the global in-vitro diagnostics company, announces that its Quo-Test ® HbA1c analyzer is successfully supporting improved medical management of patients with sight-threatening ...
Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing The study aimed to evaluate the four POC HbA1c instruments according to Clinical and Laboratory ...
GROVE CITY, Ohio, Oct. 6, 2025 /PRNewswire/ -- Tosoh Bioscience, Inc., a market leader in clinical diagnostics is proud to announce that it has received US FDA 510(k) clearance for its next-generation ...
Dublin, Oct. 08, 2025 (GLOBE NEWSWIRE) -- The "HbA1c Analyzers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product ...
Please provide your email address to receive an email when new articles are posted on . Roche’s cobas c 513 analyzer and HbA1c Gen. 3 assay has received clearance from the FDA, according to a company ...
Editor’s Note: This article originally appeared on Abbott’s website. ABBOTT PARK, Ill., May 31, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today the launch of its Afinion™ 2 analyzer in the U.S.
NEW YORK, July 4, 2019 /PRNewswire/ -- The increasing prevalence of diabetes remains a key factor fuelling HbA1c sales globally. Increasing geriatric population and the different advantages of HbA1c ...
(MENAFN- GlobeNewsWire - Nasdaq) The HbA1c analyzers market presents key opportunities in the integration of POC testing solutions, expansion in emerging markets like India and Brazil, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results